Position in ALT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$109,799
+$45,964 QoQ
Shares Held
35,650
+101.6% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EverSource Wealth Advisors, LLC holds $14,907,957 across 265 Biotechnology names. ALT ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
89,683 | $4,266,217 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,880 | $1,452,556 | |
| 3 | INCY |
Incyte Corp
|
13,070 | $1,230,145 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,507 | $672,929 | |
| 5 | RPRX |
Royalty Pharma plc
|
12,629 | $605,808 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
26,026 | $544,460 | |
| 7 | EXEL |
Exelixis, Inc.
|
11,015 | $472,428 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
6,845 | $386,665 |
All Filings in ALT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $109,799 | 35,650 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $63,835 | 17,683 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $60,444 | 16,033 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $464 | 120 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $86 | 12 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||